COVID-19 antivirals

FDA’s okay of pharmacist-prescribed antivirals praised

FDA’s okay of pharmacist-prescribed antivirals praised

WASHINGTON – Pharmacy groups praised the U.S. Food and Drug Administration on the revised Emergency Use Authorization (EUA) for Paxlovid (nirmatrelvir and ritonavir), to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients, with certain limitations to ensure appropriate patient assessment and prescribing of Paxlovid. “The FDA’s action is an extremely important revision for patient access